Concord Biotech Ltd - 543960 - Correction In Dividend % Mentioned In The Outcome Of Board Meeting Held Today I.E. Thursday, May 23, 2024- Audited Financial Results For The Quarter And Financial Year Ended On March 31, 2024
The Board of Directors ("the Board") as its meeting held on 23rd May, 2024 has recommended Dividend of Rs. 8.75 (@30%) per Equity Share of Face Value of Re. 1 Each Fully paid up for the Financial Year 2023-24, subject to approval by shareholders of the company at the ensuing AGM Due to typographical error the % was mentioned as 30% instead of 875% which is the correct figure.23-05-2024